Research Paper Volume 14, Issue 16 pp 6780—6795
High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer
Figure 3. Survival and clinical association of CCNB1 as an independent prognostic factor in BC. (A) The survival analysis was performed for OS, RFS and DMFS. The CCNB1 high expression group had a considerably shorter survival duration than the CCNB1 low expression group. (B) Univariate and multivariate analyses of factors related to survival. (C) Clinical characteristics associated with CCNB1. It can be seen that CCNB1 is highly expressed in ER (−), lymphnode (+), and p53 (+) groups. Abbreviations: OS: overall survival; RFS: recurrence free survival; DMFS: distant metastasis free survival.